These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17637398)

  • 1. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy.
    Kry SF; Followill D; White RA; Stovall M; Kuban DA; Salehpour M
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1265-71. PubMed ID: 17637398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
    Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1195-203. PubMed ID: 15990025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
    Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.
    Zwahlen DR; Ruben JD; Jones P; Gagliardi F; Millar JL; Schneider U
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):539-45. PubMed ID: 19427555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
    Johansen S; Cozzi L; Olsen DR
    Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203).
    Schneider U
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1290; author reply 1290-1. PubMed ID: 16504771
    [No Abstract]   [Full Text] [Related]  

  • 11. Second cancers in children treated with modern radiotherapy techniques.
    Schneider U; Lomax A; Timmermann B
    Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT.
    Sharma SD; Upreti RR; Laskar S; Tambe CM; Deshpande DD; Shrivastava SK; Dinshaw KA
    Radiother Oncol; 2008 Feb; 86(2):177-81. PubMed ID: 18082906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
    Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
    Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
    Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
    J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for the evaluation of uncertainty in dose-volume histogram computation.
    Henríquez FC; Castrillón SV
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1263-71. PubMed ID: 18313532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of 60Co intensity-modulated radiation therapy.
    Fox C; Romeijn HE; Lynch B; Men C; Aleman DM; Dempsey JF
    Phys Med Biol; 2008 Jun; 53(12):3175-88. PubMed ID: 18506074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
    Shi C; Peñagarícano J; Papanikolaou N
    Med Dosim; 2008; 33(3):215-21. PubMed ID: 18674686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
    Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
    Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.